End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2 MYR | 0.00% | +0.50% | +38.89% |
05-08 | KPJ Healthcare Seeks Renewal of Share Buyback Mandate | MT |
05-01 | KPJ Healthcare Seeks Renewal of Revenue-Generating Transaction Mandate | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 38.68 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+38.89% | 1.85B | B+ | ||
-20.29% | 16.5B | B+ | ||
+4.50% | 12.81B | B | ||
+3.32% | 11.7B | B+ | ||
+2.54% | 10.09B | B+ | ||
+30.53% | 8.75B | B | ||
-3.46% | 7.77B | A- | ||
+6.30% | 6.67B | B- | ||
+8.41% | 6.42B | D | ||
+46.06% | 4.54B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- KPJ Stock
- Ratings KPJ Healthcare